Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 70 entries
Sorted by: Best Match Show Resources per page
[Revision of the TNM Stage Grouping in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer

Ye B, Zhao H.
PMID: 27335292
Zhongguo Fei Ai Za Zhi. 2016 Jun 20;19(6):337-42. doi: 10.3779/j.issn.1009-3419.2016.06.07.

The currently adopted staging system for lung cancer is the seventh edition of the TNM staging edited by Union for International Cancer Control (UICC) in January, 2009. In recent years, with the advances of techniques in lung cancer diagnosis...

Cite
Ye B, Zhao H. [Revision of the TNM Stage Grouping in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2016;19(6):337-42doi: 10.3779/j.issn.1009-3419.2016.06.07.
Ye, B., & Zhao, H. (2016). [Revision of the TNM Stage Grouping in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 19(6), 337-42. https://doi.org/10.3779/j.issn.1009-3419.2016.06.07
Ye, Bo, and Zhao, Heng. "[Revision of the TNM Stage Grouping in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer]." Zhongguo fei ai za zhi = Chinese journal of lung cancer vol. 19,6 (2016): 337-42. doi: https://doi.org/10.3779/j.issn.1009-3419.2016.06.07
Ye B, Zhao H. [Revision of the TNM Stage Grouping in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2016 Jun 20;19(6):337-42. doi: 10.3779/j.issn.1009-3419.2016.06.07. Chinese. PMID: 27335292; PMCID: PMC6015190.
Copy Download .nbib Format: NLM
Availability of TNM Staging Data Elements in the Medical Record and Training Needs Assessment: Results from the 2014 SEER Training Needs Assessment for TNM Study.

Journal of registry management

Noone AM, Schussler N, Negoita S, Adamo M, Cronin K, Cyr J, Gress D, Grove C, Kosary C, Liu B, Sun L, Ward K, Penberthy L.
PMID: 26360105
J Registry Manag. 2015;42(2):40-7.

BACKGROUND: In 2016, the cancer registry community will directly assign T, N and M components of stage. The Surveillance, Epidemiology, and End Results program implemented a field study to determine how often T, N and M were not available...

Cite
Noone AM, Schussler N, Negoita S, et al. Availability of TNM Staging Data Elements in the Medical Record and Training Needs Assessment: Results from the 2014 SEER Training Needs Assessment for TNM Study. J Registry Manag. 2015;42(2):40-7
Noone, A. M., Schussler, N., Negoita, S., Adamo, M., Cronin, K., Cyr, J., Gress, D., Grove, C., Kosary, C., Liu, B., Sun, L., Ward, K., & Penberthy, L. (2015). Availability of TNM Staging Data Elements in the Medical Record and Training Needs Assessment: Results from the 2014 SEER Training Needs Assessment for TNM Study. Journal of registry management, 42(2), 40-7.
Noone, Anne-Michelle, et al. "Availability of TNM Staging Data Elements in the Medical Record and Training Needs Assessment: Results from the 2014 SEER Training Needs Assessment for TNM Study." Journal of registry management vol. 42,2 (2015): 40-7.
Noone AM, Schussler N, Negoita S, Adamo M, Cronin K, Cyr J, Gress D, Grove C, Kosary C, Liu B, Sun L, Ward K, Penberthy L. Availability of TNM Staging Data Elements in the Medical Record and Training Needs Assessment: Results from the 2014 SEER Training Needs Assessment for TNM Study. J Registry Manag. 2015;42(2):40-7. PMID: 26360105.
Copy Download .nbib Format: NLM
[EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease].

Actas urologicas espanolas

Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F.
PMID: 21757259
Actas Urol Esp. 2011 Oct;35(9):501-14. doi: 10.1016/j.acuro.2011.04.004. Epub 2011 Jul 14.

OBJECTIVE: Our aim was to present a summary of the 2010 version of the European Association of Urology (EAU) guidelines on the screening, diagnosis, and treatment of clinically localised cancer of the prostate (PCa).METHODS: The working panel performed a...

Cite
Heidenreich A, Bellmunt J, Bolla M, et al. Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado. [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. Actas Urol Esp. 2011;35(9):501-14doi: 10.1016/j.acuro.2011.04.004.
Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Mason, M., Matveev, V., Mottet, N., Schmid, H. P., van der Kwast, T., Wiegel, T., & Zattoni, F. (2011). Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado. [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. Actas urologicas espanolas, 35(9), 501-14. https://doi.org/10.1016/j.acuro.2011.04.004
Heidenreich, A, et al. "Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado." [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. Actas urologicas espanolas vol. 35,9 (2011): 501-14. doi: https://doi.org/10.1016/j.acuro.2011.04.004
Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F. Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado. [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. Actas Urol Esp. 2011 Oct;35(9):501-14. doi: 10.1016/j.acuro.2011.04.004. Epub 2011 Jul 14. Spanish. PMID: 21757259.
Copy Download .nbib Format: NLM
The fifth "C" is cost: highlights from ASCO 2011.

Journal of the National Comprehensive Cancer Network : JNCCN

Burstein HJ.
PMID: 21715720
J Natl Compr Canc Netw. 2011 Jul 01;9(7):691. doi: 10.6004/jnccn.2011.0059.

No abstract available.

Cite
Burstein HJ. The fifth "C" is cost: highlights from ASCO 2011. J Natl Compr Canc Netw. 2011;9(7):691doi: 10.6004/jnccn.2011.0059.
Burstein, H. J. (2011). The fifth "C" is cost: highlights from ASCO 2011. Journal of the National Comprehensive Cancer Network : JNCCN, 9(7), 691. https://doi.org/10.6004/jnccn.2011.0059
Burstein, Harold J. "The fifth "C" is cost: highlights from ASCO 2011." Journal of the National Comprehensive Cancer Network : JNCCN vol. 9,7 (2011): 691. doi: https://doi.org/10.6004/jnccn.2011.0059
Burstein HJ. The fifth "C" is cost: highlights from ASCO 2011. J Natl Compr Canc Netw. 2011 Jul 01;9(7):691. doi: 10.6004/jnccn.2011.0059. PMID: 21715720.
Copy Download .nbib Format: NLM
[Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung cancer].

Revue de pneumologie clinique

Khalil A, Thomassin-Naggara I, Gounant V, Nedelcu N, Marsault C, Carette MF.
PMID: 19306784
Rev Pneumol Clin. 2009 Feb;65(1):40-8. doi: 10.1016/j.pneumo.2008.08.001. Epub 2009 Jan 08.

Tissue characterization is a major and ultimate goal of imaging, whether morphological (Computed Tomography, Magnetic Resonance Imaging) or metabolic (PET-FDG-[18F]). Functional imaging, using the MRI, began several years ago with the perfusion of lung nodules and very recently with...

Cite
Khalil A, Thomassin-Naggara I, Gounant V, et al. IRM de perfusion et de diffusion dans le bilan initial et le suivi des patients atteints de cancer bronchique. [Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung cancer]. Rev Pneumol Clin. 2009;65(1):40-8doi: 10.1016/j.pneumo.2008.08.001.
Khalil, A., Thomassin-Naggara, I., Gounant, V., Nedelcu, N., Marsault, C., & Carette, M. F. (2009). IRM de perfusion et de diffusion dans le bilan initial et le suivi des patients atteints de cancer bronchique. [Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung cancer]. Revue de pneumologie clinique, 65(1), 40-8. https://doi.org/10.1016/j.pneumo.2008.08.001
Khalil, A, et al. "IRM de perfusion et de diffusion dans le bilan initial et le suivi des patients atteints de cancer bronchique." [Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung cancer]. Revue de pneumologie clinique vol. 65,1 (2009): 40-8. doi: https://doi.org/10.1016/j.pneumo.2008.08.001
Khalil A, Thomassin-Naggara I, Gounant V, Nedelcu N, Marsault C, Carette MF. IRM de perfusion et de diffusion dans le bilan initial et le suivi des patients atteints de cancer bronchique. [Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung cancer]. Rev Pneumol Clin. 2009 Feb;65(1):40-8. doi: 10.1016/j.pneumo.2008.08.001. Epub 2009 Jan 08. French. PMID: 19306784.
Copy Download .nbib Format: NLM
Head and neck cancers.

Journal of the National Comprehensive Cancer Network : JNCCN

Forastiere AA, Ang K, Brizel D, Brockstein BE, Dunphy F, Eisele DW, Goepfert H, Hicks WL, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A, Wheeler RH, Wolf GT, Worden F, Yueh B.
PMID: 16002004
J Natl Compr Canc Netw. 2005 May;3(3):316-91. doi: 10.6004/jnccn.2005.0019.

No abstract available.

Cite
Forastiere AA, Ang K, Brizel D, et al. Head and neck cancers. J Natl Compr Canc Netw. 2005;3(3):316-91doi: 10.6004/jnccn.2005.0019.
Forastiere, A. A., Ang, K., Brizel, D., Brockstein, B. E., Dunphy, F., Eisele, D. W., Goepfert, H., Hicks, W. L., Kies, M. S., Lydiatt, W. M., Maghami, E., McCaffrey, T., Mittal, B. B., Pfister, D. G., Pinto, H. A., Posner, M. R., Ridge, J. A., Samant, S., Schuller, D. E., Shah, J. P., Spencer, S., Trotti, A., Wheeler, R. H., Wolf, G. T., Worden, F., Yueh, B. (2005). Head and neck cancers. Journal of the National Comprehensive Cancer Network : JNCCN, 3(3), 316-91. https://doi.org/10.6004/jnccn.2005.0019
Forastiere, Arlene A, et al. "Head and neck cancers." Journal of the National Comprehensive Cancer Network : JNCCN vol. 3,3 (2005): 316-91. doi: https://doi.org/10.6004/jnccn.2005.0019
Forastiere AA, Ang K, Brizel D, Brockstein BE, Dunphy F, Eisele DW, Goepfert H, Hicks WL, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A, Wheeler RH, Wolf GT, Worden F, Yueh B. Head and neck cancers. J Natl Compr Canc Netw. 2005 May;3(3):316-91. doi: 10.6004/jnccn.2005.0019. PMID: 16002004.
Copy Download .nbib Format: NLM
[Current status of initial staging and posttreatment response evaluation in esophageal carcinoma].

Nihon Geka Gakkai zasshi

Yasuda T, Imamoto H, Shiozaki H.
PMID: 18320803
Nihon Geka Gakkai Zasshi. 2008 Jan;109(1):3-9.

There has been remarkable progress in diagnostic modalities in recent years. The development of endoscopic instruments and introduction of fluoro deoxy glucose-positron emission tomography (FDG-PET) and sentinel node (SN) diagnosis markedly improved diagnostic quality. The requirement for individualized treatment...

Cite
Yasuda T, Imamoto H, Shiozaki H. [Current status of initial staging and posttreatment response evaluation in esophageal carcinoma]. Nihon Geka Gakkai Zasshi. 2008;109(1):3-9
Yasuda, T., Imamoto, H., & Shiozaki, H. (2008). [Current status of initial staging and posttreatment response evaluation in esophageal carcinoma]. Nihon Geka Gakkai zasshi, 109(1), 3-9.
Yasuda, Takushi, et al. "[Current status of initial staging and posttreatment response evaluation in esophageal carcinoma]." Nihon Geka Gakkai zasshi vol. 109,1 (2008): 3-9.
Yasuda T, Imamoto H, Shiozaki H. [Current status of initial staging and posttreatment response evaluation in esophageal carcinoma]. Nihon Geka Gakkai Zasshi. 2008 Jan;109(1):3-9. Japanese. PMID: 18320803.
Copy Download .nbib Format: NLM
Surgery effective for advanced form of prostate cancer.

Mayo Clinic health letter (English ed.)

[No authors listed]
PMID: 16229075
Mayo Clin Health Lett. 2005 Aug;23(8):4.

No abstract available.

Cite
Surgery effective for advanced form of prostate cancer. Mayo Clin Health Lett. 2005;23(8):4
(2005). Surgery effective for advanced form of prostate cancer. Mayo Clinic health letter (English ed.), 23(8), 4.
"Surgery effective for advanced form of prostate cancer." Mayo Clinic health letter (English ed.) vol. 23,8 (2005): 4.
Surgery effective for advanced form of prostate cancer. Mayo Clin Health Lett. 2005 Aug;23(8):4. PMID: 16229075.
Copy Download .nbib Format: NLM
Whole body diffusion weighted imaging: a new era of oncological radiology.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih

Jin ZY, Xue HD, Tao H.
PMID: 18853845
Chin Med Sci J. 2008 Sep;23(3):129-32. doi: 10.1016/s1001-9294(09)60026-2.

Cancer has become the leading cause of mortality in the urban area of China. Whole body diffusion weighted imaging (WB-DWI), also known as virtual positron emission tomography, has gradually become accepted as an image tool in tumor localization, characterization,...

Cite
Jin ZY, Xue HD, Tao H. Whole body diffusion weighted imaging: a new era of oncological radiology. Chin Med Sci J. 2008;23(3):129-32doi: 10.1016/s1001-9294(09)60026-2.
Jin, Z. Y., Xue, H. D., & Tao, H. (2008). Whole body diffusion weighted imaging: a new era of oncological radiology. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 23(3), 129-32. https://doi.org/10.1016/s1001-9294(09)60026-2
Jin, Zheng-Yu, et al. "Whole body diffusion weighted imaging: a new era of oncological radiology." Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih vol. 23,3 (2008): 129-32. doi: https://doi.org/10.1016/s1001-9294(09)60026-2
Jin ZY, Xue HD, Tao H. Whole body diffusion weighted imaging: a new era of oncological radiology. Chin Med Sci J. 2008 Sep;23(3):129-32. doi: 10.1016/s1001-9294(09)60026-2. PMID: 18853845.
Copy Download .nbib Format: NLM
Sentinel lymph node biopsy for melanoma of the head and neck.

Expert review of anticancer therapy

Lentsch EJ, McMasters KM.
PMID: 14599090
Expert Rev Anticancer Ther. 2003 Oct;3(5):673-83. doi: 10.1586/14737140.3.5.673.

Since its first description nearly two centuries ago, melanoma has been a difficult disease to diagnose and treat. With the incidence and mortality rates slowly increasing, understanding this disease is more important than ever. Herein, the current diagnostic and...

Cite
Lentsch EJ, McMasters KM. Sentinel lymph node biopsy for melanoma of the head and neck. Expert Rev Anticancer Ther. 2003;3(5):673-83doi: 10.1586/14737140.3.5.673.
Lentsch, E. J., & McMasters, K. M. (2003). Sentinel lymph node biopsy for melanoma of the head and neck. Expert review of anticancer therapy, 3(5), 673-83. https://doi.org/10.1586/14737140.3.5.673
Lentsch, Eric J, and McMasters, Kelly M. "Sentinel lymph node biopsy for melanoma of the head and neck." Expert review of anticancer therapy vol. 3,5 (2003): 673-83. doi: https://doi.org/10.1586/14737140.3.5.673
Lentsch EJ, McMasters KM. Sentinel lymph node biopsy for melanoma of the head and neck. Expert Rev Anticancer Ther. 2003 Oct;3(5):673-83. doi: 10.1586/14737140.3.5.673. PMID: 14599090.
Copy Download .nbib Format: NLM
[Current validity of nomograms for prostate cancer staging].

Archivos espanoles de urologia

Fernando AB, Sanz G, Esteban LM, Sanz MJ, Martínez PG, de Jalón AG, Frago PS, Losa CA, Sanz LA.
PMID: 17283712
Arch Esp Urol. 2006 Dec;59(10):989-1000.

OBJECTIVE: [corrected] This paper presents a review of the concept of "nomogram" applied to prostate cancer, and specifically as a staging tool.METHODS/RESULTS: We describe the essential parameters for the evaluation of such type of predictive models: Calibration, discrimination and...

Cite
Fernando AB, Sanz G, Esteban LM, et al. Vigencia actual de los nomogramas en la estadificación del cáncer de próstata. [Current validity of nomograms for prostate cancer staging]. Arch Esp Urol. 2006;59(10):989-1000
Fernando, A. B., Sanz, G., Esteban, L. M., Sanz, M. J., Martínez, P. G., de Jalón, A. G., Frago, P. S., Losa, C. A., & Sanz, L. A. (2006). Vigencia actual de los nomogramas en la estadificación del cáncer de próstata. [Current validity of nomograms for prostate cancer staging]. Archivos espanoles de urologia, 59(10), 989-1000.
Fernando, Angel Borque, et al. "Vigencia actual de los nomogramas en la estadificación del cáncer de próstata." [Current validity of nomograms for prostate cancer staging]. Archivos espanoles de urologia vol. 59,10 (2006): 989-1000.
Fernando AB, Sanz G, Esteban LM, Sanz MJ, Martínez PG, de Jalón AG, Frago PS, Losa CA, Sanz LA. Vigencia actual de los nomogramas en la estadificación del cáncer de próstata. [Current validity of nomograms for prostate cancer staging]. Arch Esp Urol. 2006 Dec;59(10):989-1000. Spanish. PMID: 17283712.
Copy Download .nbib Format: NLM
Multiple prognostic factors and outcome analysis in patients with cancer. Communication from the American Joint Committee on Cancer.

Cancer

Fielding LP, Henson DE.
PMID: 8453566
Cancer. 1993 Apr 01;71(7):2426-9. doi: 10.1002/1097-0142(19930401)71:7<2426::aid-cncr2820710742>3.0.co;2-l.

The authors report the establishment of a new Committee of the American Joint Committee on Cancer that has two objectives as follows: (1) to review the methods available to estimate outcome and (2) to study certain tumors to determine...

Cite
Fielding LP, Henson DE. Multiple prognostic factors and outcome analysis in patients with cancer. Communication from the American Joint Committee on Cancer. Cancer. 1993;71(7):2426-9doi: 10.1002/1097-0142(19930401)71:7<2426::aid-cncr2820710742>3.0.co;2-l.
Fielding, L. P., & Henson, D. E. (1993). Multiple prognostic factors and outcome analysis in patients with cancer. Communication from the American Joint Committee on Cancer. Cancer, 71(7), 2426-9. https://doi.org/10.1002/1097-0142(19930401)71:7<2426::aid-cncr2820710742>3.0.co;2-l
Fielding, L P, and Henson, D E. "Multiple prognostic factors and outcome analysis in patients with cancer. Communication from the American Joint Committee on Cancer." Cancer vol. 71,7 (1993): 2426-9. doi: https://doi.org/10.1002/1097-0142(19930401)71:7<2426::aid-cncr2820710742>3.0.co;2-l
Fielding LP, Henson DE. Multiple prognostic factors and outcome analysis in patients with cancer. Communication from the American Joint Committee on Cancer. Cancer. 1993 Apr 01;71(7):2426-9. doi: 10.1002/1097-0142(19930401)71:7<2426::aid-cncr2820710742>3.0.co;2-l. PMID: 8453566.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 70 entries